Citations

Mayo Clinic

Showing 10 of 108106 citations.

Skin Injury with the Use of a Water Warming Device
Gali, Bhargavi , Findlay, James Y. , Plevak, David J.

Anesthesiology | November 10, 2003 | Volume: 98 | Issue: 6 | Pages: 1509-1510

10.1097/00000542-200306000-00032 | PMID 12766666 Get It

Unusual Cause of Intraoperative Urinary Retention
Bergman, Bradley D., Šprung, Juraj

Anesthesiology | November 10, 2003 | Volume: 98 | Issue: 4 | Pages: 1030-1031

10.1097/00000542-200304000-00050 | PMID 12657877 Get It

Effect of Low Isoflurane Concentrations on the Ventilation–Perfusion Distribution in Injured Canine Lungs
Putensen, Christian , Räsänen, Jukka, Putensen-Himmer, Gabriele, Downs, John B.

Anesthesiology | November 10, 2003 | Volume: 97 | Issue: 3 | Pages: 652-659

10.1097/00000542-200209000-00020 | PMID 12218533 Get It

Background Rapid recovery and weaning from ventilatory support and cardiovascular stability are suggested advantages of isoflurane inhalation, in concentrations ranging from 0.1 to 0.6 vol%, for long-term sedation in mechanical ventilated patients. This study was designed to determine whether isoflurane in low concentrations impairs pulmonary gas exchange by increasing ventilation and perfusion (V(A)/Q) mismatch during lung injury. Methods Fourteen anesthetized dogs received in random order 0, 0.25, or 0.5 vol% end-tidal isoflurane before and after induction of lung injury with oleic acid. Gas exchange was assessed by blood gas analysis and by estimating the V(A)/Q distributions using the multiple inert gas elimination technique. Results Administration of oleic acid produced a lung injury with severe V(A)/Q mismatch and 38 +/- 4% intrapulmonary shunting of blood. During lung injury, isoflurane accounted for a dose-related increase in blood flow to shunt units from 38 +/- 4 to 42 +/- 3 (0.25 vol%) and 48 +/- 4% (0.5 vol%) (P < 0.05), dispersion pulmonary blood flow distribution from 0.94 +/- 0.07 to 1.01 +/- 0.09 (0.25 vol%) and 1.11 +/- 0.11% (0.5 vol%) (P < 0.05), and a decrease in perfusion of normal V(A)/Q units from 58 +/- 5 to 55 +/- 4 (0.25 vol%) and 50 +/- 4% (0.5 vol%) (P < 0.05) (mean +/- SE). Isoflurane decreased arterial oxygen partial pressure from 72 +/- 4 to 62 +/- 4 mmHg (0.25 vol%) and 56 +/- 4 mmHg (0.5 vol%) (P < 0.05) and oxygen delivery from 573 +/- 21 to 529 +/- 19 ml. kg. min (0.25 vol%) and 505 +/- 22 ml. kg. min (0.5 vol%) (P < 0.05). Gas exchange, perfusion of shunt and normal V(A)/Q units, and pulmonary blood flow distribution was similar in absence of lung injury with and without isoflurane. Isoflurane 0.5 vol% lowered cardiac output during all conditions (P < 0.05). CONCLUSIONS Inhalation of low concentrations of isoflurane contributed to increased V(A)/Q mismatch and decreased systemic blood flow and oxygen delivery in mechanically ventilated animals with injured lungs.
Intraoperative Low-volume Acute Normovolemic Hemodilution in Adult Open-heart Surgery
Casati, Valter, Speziali, Giovanni, D'Alessandro, Cesare, Cianchi, Clara, Grasso, Maria Antonietta, Spagnolo, Salvatore, Sandrelli, Luca, Grasso, Maria Antonietta

Anesthesiology | November 10, 2003 | Volume: 97 | Issue: 2 | Pages: 367-373

10.1097/00000542-200208000-00013 | PMID 12151926 Get It

Background Recently, various studies have questioned the efficacy of intraoperative acute normovolemic hemodilution (ANH) in reducing bleeding and the need for allogeneic transfusions in cardiac surgery. The aim of the present study was to reevaluate the effects of a low-volume ANH in elective, adult open-heart surgery. Methods Two hundred four consecutive adult patients undergoing cardiac surgery were prospectively randomized in a nonblinded manner into two groups: ANH group (103 patients), where 5-8 ml/kg of blood was withdrawn before systemic heparinization and replaced with colloid solutions, and a control group, where no hemodilution was performed (101 patients). Procedures included single and multiple valve surgery, aortic root surgery, coronary surgery combined with valve surgery, or partial left ventriculectomy. The purpose of the study was to evaluate the efficacy of ANH in reducing the need for allogeneic blood components. Routine hematochemical evaluations, perioperative blood loss, major complications, and outcomes were also recorded. Results No differences were found between the groups regarding demographics, baseline hematochemical data, and operative characteristics. There was no difference in the amount of transfusions of packed red cells, fresh frozen plasma, platelet concentrates, total number of patients transfused (control group, 36% vs. ANH group, 34.3%; P = 0.88), and amount of postoperative bleeding (control group, 412 ml [313-552 ml] vs. ANH group, 374 ml [255-704 ml]) (median [25th-75th percentiles]); P = 0.94. Further, perioperative complications, postoperative hematochemical data, and outcomes were not different. Conclusions In patients undergoing elective open-heart surgery, low-volume ANH showed lack of efficacy in reducing the need for allogeneic transfusions and postoperative bleeding.
Pneumatic Compression Boots, Lithotomy Stirrups, and Lower Limb Compartment Syndrome
Warner, Mark A. , Halliwill, John R.

Anesthesiology | November 10, 2003 | Volume: 97 | Issue: 1 | Pages: 285-285

10.1097/00000542-200207000-00055 Get It

Esmolol Improves Left Ventricular Function via  Enhanced β-Adrenergic Receptor Signaling in a Canine Model of Coronary Revascularization
Booth, John V., McRae, Robert L., Chesnut, Lynn C., El-Moalem, Habib, Atwell, Darryl M., Leone, Bruce J. , Schwinn, Debra A. , Spahn, Donat R.

Anesthesiology | November 10, 2003 | Volume: 97 | Issue: 1 | Pages: 162-169

10.1097/00000542-200207000-00023 | PMID 12131118 Get It

Background Recent American Heart Association guidelines highlight the paucity of data on effectiveness and/or mechanisms underlying use of beta-adrenergic receptor (beta AR) antagonists after acute coronary syndromes in patients subsequently undergoing revascularization. It is important to assess whether beta AR antagonists might protect the heart and improve ventricular function in this scenario. The authors therefore used esmolol (an ultra-short-acting beta AR antagonist) to determine whether beta AR antagonist treatment improves left ventricular function in a canine model of acute reversible coronary ischemia followed by coronary reperfusion during cardiopulmonary bypass (CPB). The authors also tested whether the mechanism includes preserved beta AR signaling. Methods Dogs were randomized to either esmolol or saline infusions administered during CPB (n = 29). Pre-CPB and end-CPB transmyocardial left ventricular biopsies were obtained; plasma catecholamine concentrations, myocardial beta AR density, and adenylyl cyclase activity were measured. In addition, left ventricular systolic shortening and postsystolic shortening were determined immediately prior to each biopsy. Results While beta AR density remained unchanged in each group, isoproterenol-stimulated adenylyl cyclase activity decreased 26 +/- 6% in the control group but increased 38 +/- 10% in the esmolol group (pre-CPB to end-CPB, mean +/- SD, P = 0.0001). Left ventricular systolic shortening improved in both groups after release of coronary (LAD) ligature; however, the esmolol group increased to 72 +/- 23% of pre-CPB values compared to 48 +/- 12% for the control group (P = 0.0008). Conclusions These data provide prospective evidence that esmolol administration results in improved myocardial function. Furthermore, the mechanism appears to involve enhanced myocardial beta AR signaling.
An Unexplained Death
Knight, Paul R. , Bacon, Douglas R.

Anesthesiology | November 10, 2003 | Volume: 96 | Issue: 5 | Pages: 1250-1253

10.1097/00000542-200205000-00030 | PMID 11981167 Get It

Frequency of Myocardial Infarction, Pulmonary Embolism, Deep Venous Thrombosis, and Death following Primary Hip or Knee Arthroplasty
Wood, Margaret, Mantilla, Carlos B. , Horlocker, Terese T. , Schroeder, Darrell R. , Brown, David , Berry, Daniel J. , Mantilla, Carlos B , Schroeder, Darrell

Anesthesiology | November 10, 2003 | Volume: 96 | Issue: 5 | Pages: 1140-1146

10.1097/00000542-200205000-00017 | PMID 11981154 Get It

Background There is limited information about the frequency of perioperative complications after elective primary orthopedic total hip and knee arthroplasty in contemporary practice. The purpose of this study was to determine the frequency of clinically relevant myocardial infarction, pulmonary embolism, deep venous thrombosis, and death within 30 days after elective primary hip or knee arthroplasty treated according to contemporary perioperative management. Methods The authors examined the medical records of consecutive patients undergoing hip or knee arthroplasty at their institution in a 10-yr period. Prospectively collected databases were used to identify patients with the diagnosis of myocardial infarction, pulmonary embolism, deep venous thrombosis, or death using strict validation criteria and diagnostic-certainty categories. Results A total of 10,244 patients underwent primary total hip or knee arthroplasty in the period of study. Of these, 224 patients had one or more adverse events (overall event rate: 2.2%; myocardial infarction: 0.4%; pulmonary embolism: 0.7%; deep venous thrombosis: 1.5%; death: 0.5%). Most adverse events (myocardial infarction, pulmonary embolism, and death) increased in frequency with older age, particularly for patients aged 70 yr or older. Myocardial infarction occurred more frequently in male patients. There were no differences in the overall event frequency between types of procedure. However, pulmonary embolism was highest in patients undergoing bilateral knee operations. Conclusions The overall frequency of serious complications within 30 days after primary total hip or knee arthroplasty with contemporary practice was 2.2%. Accurate knowledge of the perioperative risks associated with widely performed elective operations can be used to implement management strategies that may further improve patient outcomes and decrease cost.
Effects of Primary Alcohols on Airway Smooth Muscle
Sakihara, Chie, Lorenz, Robert R. , Perkins, William J., Jones, Keith , Warner, David O.

Anesthesiology | November 10, 2003 | Volume: 96 | Issue: 2 | Pages: 428-437

10.1097/00000542-200202000-00031 | PMID 11818778 Get It

Background The investigation examined whether primary alcohols could be used as tools to explore the mechanism of anesthetic actions in airway smooth muscle (ASM). The hypothesis was that, like volatile anesthetics, the primary alcohols relax intact ASM by decreasing intracellular Ca2+ concentration ([Ca2+]i) and by inhibiting agonist-induced increases in the force developed for a given [Ca2+]i (Ca2+ sensitivity). Method The effects of butanol, hexanol, and octanol on isometric force in canine tracheal smooth muscle were examined. The effects of hexanol on [Ca2+]i (measured with fura-2) and the relationship between force and [Ca2+]i were studied during membrane depolarization provided by KCl and during muscarinic stimulation provided by acetylcholine. Results The primary alcohols relaxed ASM contracted by KCl or acetylcholine in a concentration-dependent manner, with potency increasing as chain length increased. The alcohols could completely relax the strips, even during maximal stimulation with 10 microM acetylcholine (median effective concentrations of 28 +/- 12, 1.3 +/- 0.4, and 0.14 +/- 0.05 mM [mean +/- SD] for butanol, hexanol, and octanol, respectively). Hexanol decreased both [Ca2+]i and force in a concentration-dependent manner. Hexanol decreased Ca2+ sensitivity during muscarinic stimulation but had no effect on the force-[Ca2+]i relationship in its absence. Conclusions Primary alcohols produce reversible, complete relaxation of ASM, with potency increasing as chain length increases, by decreasing [Ca2+]i and inhibiting increases in Ca2+ sensitivity produced by muscarinic receptor stimulation. These actions mimic those of volatile anesthetics on ASM, a circumstance suggesting that the primary alcohols may be useful tools for further exploring mechanisms of anesthetic effects on ASM.
Fatal Hepatitis Associated with Isoflurane Exposure and CYP2A6 Autoantibodies
Martin, Jackie L. , Keegan, Mark T. , Vasdev, G., Nyberg, Scott L. , Bourdi, Mohammed, Pohl, Lance R., Plevak, David J.

Anesthesiology | November 10, 2003 | Volume: 95 | Issue: 2 | Pages: 551-553

10.1097/00000542-200108000-00043 | PMID 11506133 Get It